All data are based on the daily closing price as of October 1, 2026
g
GemVax&KAEL
082270.KQ
8.23 USD
0.60
+7.86%
Overview
Last close
8.23 usd
Market cap
293.70M usd
52 week high
51.11 usd
52 week low
6.45 usd
Target price
N/A usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
5.3684
Price/Book Value
6.5273
Enterprise Value
384.24M usd
EV/Revenue
6.1474
EV/EBITDA
28.168
Key financials
Revenue TTM
57.94M usd
Gross Profit TTM
13.71M usd
EBITDA TTM
1.69M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
105.40M usd
Net debt
36.85M usd
About
GemVax&KAEL Co.,Ltd engages in the manufacturing and commercializing of resins and filters for semi-conductor and panel display production in South Korea. The company offers impregnated active carbon and inorganic adsorbent coating resins; CA filter for removing chemical pollution substances and harmful gases in semiconductor and LCD/PDP manufacturing process; adsorbent towers for air pollution prevention; and pressure facility for preventing equipment erosion within a substation; and 5aver, a fire evacuation mask. It also engages in the research and development of anti-cancer immunotherapeutic and peptide drugs; and provides RIAVAX, an immunotherapeutic peptide for the treatment of locally advanced or metastatic pancreatic cancer. The company was founded in 1998 and is headquartered in Daejeon, South Korea.